Latest Breaking News On - சீரம் நிறுவனம் அடார் பூனாவல்ல - Page 1 : comparemela.com

United Kingdom ok with Covishield, but has 'vaccination certification issues'

United Kingdom ok with Covishield, but has 'vaccination certification issues'
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

IndiaUnited kingdomLondonCity ofBritishAstrazeneca vaxzevriaAstrazeneca covishieldSerum institute adar poonawallaWorld health organisationAdar poonawallaModern takedaஇந்தியாஒன்றுபட்டது கிஂக்டம்லண்டன்நகரம் ஆஃப்பிரிட்டிஷ்

ITC, Auto stocks, InterGlobe Aviation and other stocks to watch out for on June 1

Credit: Pixabay Punjab National Bank It has reduced its benchmark one-year marginal cost of funds-based lending rate by 0.05 percent to 7.3 percent. Credit: BCCL Honeywell Automation India It reported a fall in its March 2021 quarter net profit to ₹104 crore from ₹111 crore. Revenue fell by over 4 percent to ₹673 crore, year-on-year. Credit: Honeywell-Automation-India Cipla The pharma giant is in talks with the government for clarity and guidance on the roadmap for importing vaccines in the country. Credit: Cipla Asian Granito India Its March 2021 quarter net profit tripled to ₹20 crore while revenue surged by over 68 percent to ₹434 crore, year-on-year. Credit: Asian-Granito-India

Serum institute adar poonawallaAdar poonawallaStocks todayStocks to watch todayStocks to buy today indiaStocks to buy todayStocks in newsStock market todayStock market newsSensexNiftyItc share priceItc q4 2021 resultsசீரம் நிறுவனம் அடார் பூனாவல்லஅடார் பூனாவல்லஸ்டாக்ஸ் இன்று

US FDA expected to authorise Pfizer Covid vaccine for teens by next week

The US Food and Drug Administration is expected to authorise Pfizer's Covid-19 vaccine for those aged 12 years and above by next week.

New yorkUnited statesIndiaUnited kingdomBrazilAmericansBrazilianBritishCenters for diseasePfizerNew york timesDrug administrationSerum institute adar poonawallaDisease controlSerum instituteSa

No lockdown, ban gatherings of over 10 people to contain Covid-19 spread: Lancet India task force

No lockdown, ban gatherings of over 10 people to contain Covid-19 spread: Lancet India task force No lockdown, ban gatherings of over 10 people to contain Covid-19 spread: Lancet India task force The Lancet India task force has suggested a complete ban on gatherings of more than 10 persons, and closure of all venues where such gatherings can take place to contain the Covid-19 spread. advertisement UPDATED: May 3, 2021 16:10 IST Lancet India task force has suggested a ban on gathering of more than 10 people to contain Covid-19 spread (AP photo) The Lancet India Task Force on Covid-19 has suggested a containment measures checklist to the central government to contain the frightening surge in the Covid-19 cases. The task force has also asserted that these measures must be done beyond the current binary discussion on a lockdown .

IndiaKarnatakaLancet india task force on covidSerum institute adar poonawallaLancet india task forceSerum instituteWhy indiaRapid antigen testsUno lockdownAn gatherings of over 10 people to contain covid 19 spread lancet india task forceஇந்தியாகர்நாடகாசீரம் நிறுவனம் அடார் பூனாவல்லசீரம் நிறுவனம்ஏன் இந்தியாஇல்லை முடக்குதல்

Can't ramp up vaccine production overnight, says SII chief Adar Poonawalla

Can t ramp up vaccine production overnight, says SII chief Adar Poonawalla Serum Institute of India chief Adar Poonawalla on Monday said that vaccine manufacturing is a spcialised process and as such the production can’t be ramped up overnight. He further added that his firm has received total orders of over 26 crore doses, of which 15 crore doses have been supplied, and 11 crore doses will be supplied in the next few months. advertisement UPDATED: May 3, 2021 22:00 IST SII CEO Poonawalla said the population of India is huge and to produce enough doses for all adults is not an easy task. (File Photo)

IndiaUnited kingdomLondonCity ofPuneMaharashtraBharatAdar poonawallaAstrazeneca covishieldBharat biotech india ltdTwitterMinistry of healthSerum institute adar poonawallaSerum institute of indiaAstrazeneca plcNovavax inc